SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90,802,681 | +33.9% | 90,815,000 | +31.6% | 5.68% | +164.7% |
| Q4 2022 | $67,802,325 | +1.3% | 69,010,000 | 0.0% | 2.14% | +32.9% |
| Q3 2022 | $66,940,000 | -0.1% | 69,010,000 | 0.0% | 1.61% | +4.9% |
| Q2 2022 | $66,983,000 | -1.0% | 69,010,000 | 0.0% | 1.54% | 0.0% |
| Q1 2022 | $67,673,000 | -0.5% | 69,010,000 | 0.0% | 1.54% | -13.6% |
| Q4 2021 | $68,018,000 | +0.3% | 69,010,000 | 0.0% | 1.78% | -9.7% |
| Q3 2021 | $67,802,000 | +17.5% | 69,010,000 | +17.5% | 1.97% | +9.2% |
| Q2 2021 | $57,717,000 | +1.7% | 58,708,000 | -0.3% | 1.81% | -20.2% |
| Q1 2021 | $56,759,000 | +1.7% | 58,877,000 | 0.0% | 2.26% | -35.2% |
| Q4 2020 | $55,835,000 | +46.9% | 58,877,000 | +42.7% | 3.50% | +1.7% |
| Q3 2020 | $38,009,000 | +44.8% | 41,266,000 | +38.3% | 3.44% | -4.5% |
| Q2 2020 | $26,252,000 | +156.4% | 29,830,000 | +134.0% | 3.60% | +87.2% |
| Q1 2020 | $10,237,000 | – | 12,749,000 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $45,147,000 | 3.42% |
| Ayrton Capital LLC | 2,000,000 | $1,982,000 | 1.87% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $68,018,000 | 1.78% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,027,000 | $73,675,000 | 1.54% |
| DeepCurrents Investment Group LLC | 33,182,000 | $32,736,000 | 1.02% |
| Penn Mutual Asset Management | 675 | $665,000 | 0.71% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,897,000 | $7,533,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,901,000 | $19,714,000 | 0.22% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,940,000 | $9,858,000 | 0.09% |
| Jefferies Group LLC | 12,740,000 | $12,658,285 | 0.07% |